Scarica Oncology Nursing Drug Handbook - v3.5.13

Scarica e condividi Oncology Nursing Drug Handbook - v3.5.13, uno degli elementi in primo piano App nella categoria Medicina.
Inoltre, qualche altro App che puoi scaricare come Inject App, Medical Dictionary Free & Offline - Diseases, Dexcom G6, ALAT, X-RAY WOW, MCQ Abubakr (ASU). Se sei soddisfatto di Oncology Nursing Drug Handbook - v3.5.13.

Rilasciata da Skyscape Medpresso Inc, Oncology Nursing Drug Handbook - v3.5.13 è una delle migliori applicazioni gratuite per telefoni cellulari attualmente disponibili. Si trova nella categoria Medicina dell'app store.

Il sistema operativo minimo per Oncology Nursing Drug Handbook - v3.5.13 è Android 5.0+ e versioni successive. Quindi devi aggiornare il telefono se non l'hai già fatto.

Su APKDroid, riceverai Oncology Nursing Drug Handbook - v3.5.13 download gratuito di APK, con l'ultima versione 3.5.13, data di pubblicazione 2020-06-25, la dimensione del file è 8.4 MB.Secondo le statistiche del Google Play Store, ci sono circa 1000 download. Le app scaricate o installate singolarmente su Android possono essere aggiornate se lo desideri. Aggiorna anche le tue app. Ti garantisce l'accesso alle funzioni più recenti e alla sicurezza e stabilità dell'app. Divertiti subito !!!

Written especially for nurses caring for patients with cancer, the 2020-2021 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. This essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.

DESCRIPTION
Completely revised and updated, the 2020-2021 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for drugs recently approved by the FDA.

Key Features

- Provides valuable information on effective symptom management, patient education, and chemotherapy administration.
- Completely revised and updated, includes separate chapters on molecular and immunologic/biologic targeted therapies
- Provides fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer
- Offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs
- New drugs include: apalutamide (Erleada™), calaspargase pegol-mknl (Asparlas™), Daunorubicin and cytarabine liposome for injection (Vyxeos®), glucarpidase (Voraxaze®), alpelisib (Piqray®), binimetinib (Mektovi®), dacomitinib (Vizimpro®), Duvelisib (Copiktra®), encorafenib (Braftovi®), erdafitinib (Balversa™), lorlatinib (Lorbrena®), anakinra (Kineret®), baricitinib (Olumiant®), sarilumab (Kevzara®), aprepitant injectable emulsion (Cinvanti®), granisetron hydrochloride extended-release injection (Sustol®), letermovir (Prevymis™), omadacycline (Nuzyra™), meropenem/vaborbactam (Vabomere™), Plazomicin (Zemdri™), baloxavir marboxil (Xofluza™), imipenem/cilastatin sodium/relebactam (Recarbrio™), eravacycline (Xerava™), delafloxacin (Baxdela™)

Faster download with slow internet connectivity